Prevention of Variceal Rebleeding by EUS-guided vs Conventional Endoscopic Therapy in Hepatocellular Carcinoma Patients

Rebleeding rate is high in hepatocellular carcinoma (HCC) patients with variceal bleeding despite conventional endoscopic therapies for esophageal and gastric varices (EV, GV). Secondary prevention of variceal rebleeding was reported to improve outcomes of HCC patients, but the optimal endoscopic approach is not well defined. In this difficult-to-manage population, variceal rebleeding rates remain substantial after conventional endoscopic therapies. n recent studies by others and our group on direct EUS-guided therapy for varices in cirrhotic patients, high technical success (90 - 100%), low p

Trial Details

NCT ID
NCT05629845
Phase
NA
Sponsor
Chinese University of Hong Kong
Status
RECRUITING
Cancer Type
Liver Cancer
Interventions
  • endoscopic ultrasound-guided therapy
  • conventional endoscopic therapy
Locations (sample)
  • Shatin, New Territories, Hong Kong|22.38333,114.18333

Key Eligibility Criteria

  • Consecutive HCC patients age 18 or older with recent (within 4 weeks of the episode) EV or GV bleeding successfully controlled by conventional endo…
  • Able to provide written informed consent to participate in the study and comply with the study procedures

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Liver Cancer Trials on Trialify →